Molecular diagnosis of kidney transplant rejection
Acute or chronic antibody-mediated rejection (ABMR) of kidney allografts is currently diagnosed by the presence of donor-specific alloantibodies and distinct pathological findings in biopsy samples. A new study highlights the potential of molecular diagnostics incorporated into standard criteria for...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
17 June 2014
|
| In: |
Nature reviews. Nephrology
Year: 2014, Volume: 10, Issue: 8, Pages: 429-430 |
| ISSN: | 1759-507X |
| DOI: | 10.1038/nrneph.2014.106 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/nrneph.2014.106 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/nrneph.2014.106 
|
| Author Notes: | Christian Morath & Martin Zeier |
| Summary: | Acute or chronic antibody-mediated rejection (ABMR) of kidney allografts is currently diagnosed by the presence of donor-specific alloantibodies and distinct pathological findings in biopsy samples. A new study highlights the potential of molecular diagnostics incorporated into standard criteria for acute ABMR to help identify patients at risk of graft loss. |
|---|---|
| Item Description: | Gesehen am 08.09.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1759-507X |
| DOI: | 10.1038/nrneph.2014.106 |